Clinical significance of the expression of transforming growth factor-β1 and connective tissue growth factor in detrusor of benign prostatic hyperplasia patients

Yi-chuan ZHANG,Le-ye HE,Zhi LONG,Xiao-hui SUN,Guo-min WANG,Xia-ming PEI,Kuang-biao ZHONG

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2011.06.017

2011-01-01

Abstract:Objective To investigate the correlation between the expression of transforming growth factor-β1 (TGF-β1 ) , connective tissue growth factor ( CTGF) in the detrusor of benign prostatic hyperplasia (BPH) patients and its clinical significance. Methods Immunohistochemical SP method was used to detect the expression of TGF-β1 and CTGF in 29 specimens of bladder wall of BPH patients. All patients were divided into 2 groups according to the meaningful value of each clinical parameter to compare the expression of TGF-β1 and CTGF. Results All the samples had different levels of TGF-β1 and CTGF expression. The TGF-β1 in BPH patients whose prostate volume (PV) was＞50 ml was not significantly different from that in patients whose PV was ≤50 ml, but CTGF in BPH patients with PV ＞50 ml was higher than that in the other team. The TGF-β1 and CTGF in groups with TZI ＞0. 65 and residual urine＞50 ml were higher than other groups with TZI ≤0. 65 and residual urine ≤50 ml, respectively. The expression levels of TGF-β1 and CTGF of detrusors were not related with IPSS, Qmax, disease duration (P＞0. 05).Pearson-analysis reavealed that there was a positive correlation between the expression of TGF-β1 and CTGF in detrusors (r = 0. 761 ,P ＜0. 01). Conclusion TGF-β1 and CTGF have a strong correlation with PV, TZI and residual urine, suggesting that these clinical parameters may be useful in assessing the degree of the detrusor fibrosis in BPH patients.